Genalyte key facts
- Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagnostics anywhere in the delivery system.
- It has raised $345.6M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Khosla Ventures, MedTech Innovator, The Invus Group, Samsara BioCapital, HBM Partners — 27 tracked in total.
- Status: Privately Held (backing).
Who backs Genalyte
27+- ·The complete investor list: 27 names
- ·Watch Genalyte: the Monday email on marks, rounds and moves
Genalyte funding rounds
No funding rounds for Genalyte are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Genalyte investors
27 investors are on record for Genalyte, including Khosla Ventures, MedTech Innovator, The Invus Group and Samsara BioCapital. By type, the record holds 5 venture capital firms and 2 private equity firms.
About Genalyte
Developer of a diagnostic testing system designed to deliver rapidly deployable mobile laboratories with real-time diagnostics anywhere in the delivery system. The company performs the majority of tests, in any healthcare setting with a rapidly deployable mobile laboratory, in under thirty minutes and the central lab handles tests that cannot be performed onsite, enabling physicians to improve the quality of care for patients and reduce resource utilization across the healthcare system.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2007
- Employees
- 86
- Website
- genalyte.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Genalyte doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.